Congenital Afibrinogenemia

Congenital afibrinogenemia is a rare inherited bleeding disorder where the body makes almost no fibrinogen, which is also called coagulation factor I. Fibrinogen is a protein in the blood that helps form a firm clot when you bleed. In this disease, fibrinogen is absent or “undetectable,” so normal clots cannot form. As a result, even small injuries can cause long or serious bleeding. This condition is present from birth. Many babies show bleeding soon after they are born, for example bleeding from the umbilical cord stump that is hard to stop. Later in life, people may have frequent nosebleeds, gum bleeding, heavy periods, or dangerous internal bleeding.

Congenital afibrinogenemia is usually passed on in an autosomal recessive way. This means that the child gets one faulty gene from each parent. The parents are usually healthy “carriers” and do not know they carry the gene. When a child receives two faulty copies, the child has the disease and has no working fibrinogen.

Congenital afibrinogenemia is a rare genetic bleeding disorder. In this disease the liver makes no fibrinogen, or almost none. Fibrinogen is a blood protein that forms a “mesh” (clot) to stop bleeding. When it is missing, blood cannot clot well, so even small injuries can bleed for a long time. [1]

Babies may show bleeding from the umbilical cord, easy bruising, nosebleeds, gum bleeding, or heavy bleeding after minor cuts or surgery. Women may have very heavy periods or bleeding after childbirth. Serious bleeding can happen inside the brain, belly, muscles, or joints. At the same time, some people can also develop blood clots, so treatment must be very carefully balanced. [2]

The disease is very rare. Studies suggest it happens in about 1 in 1,000,000 people, but it is more common in areas where marriage between close relatives (consanguinity) is frequent. In such families, the chance that both parents carry the same rare gene mistake is higher.

Congenital afibrinogenemia belongs to a group of conditions called congenital fibrinogen disorders. In these disorders, the amount or the function of fibrinogen is abnormal. Afibrinogenemia is the most severe quantitative type, because the level of fibrinogen is essentially zero.

How normal clotting works

When we get a cut, blood vessels are damaged and start to leak blood. First, tiny blood cells called platelets stick to the broken area and form a soft plug. Next, proteins in the blood work together in a “clotting cascade” to turn fibrinogen into fibrin. Fibrin is like many tiny threads that weave through the platelet plug and make it strong and stable.

In congenital afibrinogenemia, fibrinogen is missing, so these fibrin threads cannot form. The platelet plug stays weak and can break apart easily. This means bleeding lasts longer, can restart after it seems to stop, and may happen inside the body where it is not seen right away, such as in muscles, joints, or the brain.

Because clotting does not work properly, routine blood clotting tests that depend on fibrin, such as prothrombin time (PT), activated partial thromboplastin time (aPTT), thrombin time (TT), and reptilase time, become very long or may not form a clot at all. This pattern helps doctors suspect afibrinogenemia.

Other names

Doctors and experts may use different names or related terms for this condition. All of these are connected to the same basic problem: lack of fibrinogen.

1. Congenital afibrinogenemia – the most common full name, stressing that it is present from birth and involves absence of fibrinogen.

2. Hereditary afibrinogenemia – highlights that the problem is inherited through genes.

3. Inherited fibrinogen deficiency, type I (afibrinogenemia) – used in guidelines that group all fibrinogen problems and call afibrinogenemia a type I quantitative deficiency.

4. Congenital fibrinogen deficiency – afibrinogenemia subtype – used in rare disease catalogs that describe several types of congenital fibrinogen deficiency.

5. OMIM #202400 (Afibrinogenemia) – an entry number used in genetic databases such as OMIM (Online Mendelian Inheritance in Man).

Types and classifications related to congenital afibrinogenemia

Experts often talk about “types” when they describe fibrinogen disorders. These types help doctors understand how severe the problem is and how it affects the blood. Afibrinogenemia itself is one type in a larger group.

1. Type I quantitative fibrinogen disorder – afibrinogenemia
   In this type, the amount of fibrinogen in the blood is extremely low or undetectable, and both activity and antigen levels are almost zero. This is the classic congenital afibrinogenemia.

2. Type I quantitative fibrinogen disorder – hypofibrinogenemia (related condition)
   Here, fibrinogen is present but at a lower level than normal. This is milder than afibrinogenemia but is often discussed together with it because the genetic causes overlap.

3. Homozygous or compound heterozygous afibrinogenemia
   Many patients have two faulty copies of a fibrinogen gene. They may be homozygous (two identical mutations) or compound heterozygous (two different mutations), but both patterns can lead to very low or absent fibrinogen.

4. Gene-specific subtypes (FGA-, FGB-, or FGG-related afibrinogenemia)
   The disease can be further described by which of the three fibrinogen genes is affected: FGA (alpha chain), FGB (beta chain), or FGG (gamma chain). Different families may have different gene changes, but the final result is the same: lack of fibrinogen.

5. Afibrinogenemia with thrombotic tendency
   Some people with afibrinogenemia surprisingly develop blood clots (thrombosis) as well as bleeding. This appears to be a special phenotype linked to how lack of fibrin affects thrombin handling, and it is now recognized as a clinical subtype in some series.

Causes of congenital afibrinogenemia

The “cause” of congenital afibrinogenemia is genetic. Many different detailed gene changes can lead to the same final result: almost no fibrinogen in the blood. Below we explain 20 important cause-related points in simple words.

1. Mutations in fibrinogen alpha chain gene (FGA)
   One major cause is a harmful change (mutation) in the FGA gene, which gives instructions to make the alpha chain of fibrinogen. If both copies of this gene are severely damaged, the body cannot assemble normal fibrinogen, leading to afibrinogenemia.

2. Mutations in fibrinogen beta chain gene (FGB)
   A second cause is mutation in the FGB gene. This gene makes the beta chain of fibrinogen. Faulty FGB can stop fibrinogen production or cause unstable protein that is destroyed before it reaches the blood.

3. Mutations in fibrinogen gamma chain gene (FGG)
   A third cause is a mutation in the FGG gene, which makes the gamma chain. Because fibrinogen needs all three chains to assemble properly, loss of the gamma chain also results in very low or absent fibrinogen.

4. Nonsense mutations causing early stop codons
   Some mutations change a normal amino acid code into a premature “stop” signal. This is called a nonsense mutation. The cell then produces a short, incomplete fibrinogen chain that is useless, so fibrinogen is not formed.

5. Frameshift mutations
   Small insertions or deletions in the gene may shift the reading frame. This frameshift changes all the amino acids after the error and usually produces a non-functional truncated protein, leading to absence of fibrinogen.

6. Splice-site mutations
   Some mutations occur at the places where the cell cuts and joins pieces of RNA (splice sites). If splicing fails, the RNA message is wrong and the fibrinogen chain cannot be built correctly, which again means no usable fibrinogen.

7. Large deletions in fibrinogen genes
   In some families, a whole section of a fibrinogen gene is deleted. Without this section, the gene cannot instruct the cell to make the needed chain, and fibrinogen levels fall to zero.

8. Mutations that block secretion of fibrinogen
   Certain gene changes allow fibrinogen chains to form inside the cell but prevent them from being secreted into the bloodstream. The protein gets stuck or is destroyed inside the cell, so blood tests still show no fibrinogen.

9. Autosomal recessive inheritance with two defective alleles
   The basic cause at the family level is that the child inherits two defective copies (alleles) of a fibrinogen gene, one from each parent. Having two defective alleles is necessary to develop full afibrinogenemia.

10. Parental carrier status (heterozygous parents)
    Most parents are carriers. They have one normal and one faulty copy of a fibrinogen gene, so they have enough fibrinogen to clot normally. When both carriers have a child, there is a one-in-four chance the child receives both faulty copies and develops afibrinogenemia.

11. Consanguineous marriage (parents who are relatives)
    In communities where marriage between cousins or other relatives is common, both parents may carry the same rare mutation more often. This increases the chance of a child inheriting two identical faulty genes and developing afibrinogenemia.

12. Founder mutations in certain populations
    Some populations have “founder” mutations, which began many generations ago in a single ancestor. These mutations can spread within a group and cause more cases of congenital afibrinogenemia in that region compared with the general population.

13. Compound heterozygosity for two different mutations
    A person may inherit two different harmful mutations, one from each parent, in the same fibrinogen gene. Even though the mutations are different, together they prevent the gene from making functional fibrinogen.

14. Mutations affecting protein stability
    Some variants produce fibrinogen that is made but is very unstable and rapidly broken down. Over time, this can result in almost no circulating fibrinogen, functionally resembling afibrinogenemia.

15. Mutations in regulatory regions of fibrinogen genes
    Changes in promoter or regulatory regions can reduce or stop gene expression. If the cell cannot switch on the fibrinogen gene, little or no fibrinogen protein is produced.

16. Mutations affecting intracellular processing and assembly
    Some mutations disturb how the three fibrinogen chains fold and assemble into a hexameric molecule inside the liver cell. Failed assembly leads to retention and degradation of fibrinogen in the cell and almost zero level in plasma.

17. Mutations disrupting secretion from hepatocytes
    Fibrinogen is made in liver cells (hepatocytes). Changes that interfere with the secretory pathway can prevent fibrinogen from reaching the blood, even if it is partly formed.

18. Very rare de novo mutations
    In a small number of cases, a new mutation appears in the egg or sperm, so there is no family history. Even without affected relatives, this new mutation can cause afibrinogenemia in the child.

19. Genetic background and modifier genes
    Other genes that control liver function, protein folding, or clotting can modify how severe the fibrinogen deficiency is. These “modifier” genes do not cause the disease alone but can influence the final fibrinogen level and symptoms.

20. Unknown or not yet identified mutations
    In some patients, clear symptoms and lab tests show afibrinogenemia, but current genetic tests do not find the exact mutation. This suggests that there are still unidentified gene changes or regulatory defects that can cause this condition.

Symptoms and signs of congenital afibrinogenemia

Symptoms can range from mild to life-threatening. Many appear in newborns or early childhood.

1. Umbilical cord stump bleeding in newborns
   One of the earliest and most typical signs is long or heavy bleeding from the umbilical stump soon after birth. Normal babies have only small, short-lasting bleeding here, but babies with afibrinogenemia may bleed for hours or days unless treated.

2. Bleeding after circumcision or minor procedures
   Male infants may bleed a lot after circumcision. Even simple needle sticks or injections can cause large bruises or long bleeding, which alerts doctors to a clotting problem.

3. Easy bruising
   Children and adults may develop large, dark bruises from small knocks or even without clear injury. This happens because weak clots break down and allow blood to leak under the skin.

4. Frequent nosebleeds (epistaxis)
   Repeated nosebleeds are common. They may last longer than usual and can be hard to stop, especially during infections or in dry weather.

5. Gum and mouth bleeding
   People may bleed a lot from the gums during tooth brushing or dental work. Small cuts inside the mouth can also bleed for a long time.

6. Heavy menstrual bleeding (menorrhagia)
   Many women and girls with afibrinogenemia have very heavy periods. They may pass large clots, need to change pads or tampons very frequently, or develop anemia from blood loss.

7. Bleeding after childbirth or miscarriage
   Women with the disease are at high risk of heavy bleeding after delivery or pregnancy loss. They may also have recurrent miscarriages because proper fibrin formation is important for placenta attachment and pregnancy maintenance.

8. Gastrointestinal (GI) bleeding
   Blood may appear in vomit or stool, or there may be hidden GI bleeding that causes anemia. This can happen spontaneously or after ulcers or small injuries in the gut.

9. Joint bleeding (hemarthrosis)
   Bleeding into large joints such as knees, ankles, or elbows can cause swelling, pain, and reduced movement. Repeated episodes can damage the joint over time.

10. Muscle and soft tissue hematomas
    People may develop deep, painful collections of blood in muscles or under the skin (hematomas). These can appear after a fall or injection, or sometimes without clear trauma.

11. Intracranial (brain) hemorrhage
    One of the most serious complications is bleeding inside the skull or brain. It may cause headache, vomiting, seizures, weakness, or loss of consciousness and can be life-threatening.

12. Bleeding into internal organs (liver, spleen, etc.)
    Internal bleeding can occur in organs such as the liver or spleen, especially after trauma. This may cause abdominal pain, swelling, or shock if bleeding is severe.

13. Post-operative bleeding
    After surgery or dental extraction, patients with afibrinogenemia may have prolonged or recurrent bleeding, even if the procedure seemed simple. This is a common way the disease is discovered in older children or adults.

14. Signs of anemia (tiredness, pale skin, fast heartbeat)
    Long-lasting or repeated bleeding can lead to low red blood cell count (anemia). This causes fatigue, pale skin, dizziness, and sometimes rapid heartbeat, especially during exercise.

15. Occasional thrombosis (blood clots)
    Surprisingly, some patients also develop blood clots in veins or arteries, particularly during or after replacement therapy or in special situations such as surgery or pregnancy. This shows that afibrinogenemia can cause both bleeding and clotting problems in some people.

Diagnostic tests

Diagnosis of congenital afibrinogenemia requires careful history, physical exam, blood tests, and sometimes genetic tests. Doctors also use imaging tests to find internal bleeding and electrodiagnostic tests for serious complications such as brain bleeding.

Physical exam

1. General physical examination and vital signs
   The doctor checks the whole body for signs of bleeding and anemia. They look at blood pressure, pulse, breathing rate, and temperature. Low blood pressure, rapid pulse, or very pale skin can suggest serious blood loss. This exam helps judge how urgent the situation is before and after laboratory tests.

2. Skin and mucous membrane inspection
   The doctor carefully examines the skin, gums, inside of the mouth, and nose. They look for bruises, petechiae (tiny red spots), gum bleeding, or nose crusts from past bleeds. These findings support a diagnosis of a bleeding disorder like afibrinogenemia.

3. Joint and muscle examination
   Joints are checked for swelling, warmth, pain, or limited movement, which may indicate bleeding inside the joint (hemarthrosis). Muscles are examined for tenderness or firm lumps that suggest deep hematomas. This guides which joints or muscles may need imaging.

4. Neurological examination
   The doctor tests strength, sensation, balance, eye movements, and reflexes. Any abnormal findings, like weakness on one side or trouble speaking, can signal possible brain bleeding and the need for urgent imaging and treatment.

Manual and bedside assessments

5. Detailed bleeding history and bleeding score
   A careful history is one of the most important tools. The clinician asks about bleeding from birth, nosebleeds, gum bleeding, heavy periods, surgery, and family history. Standard tools such as bleeding assessment scores help measure how abnormal the bleeding pattern is compared with healthy people.

6. Family pedigree analysis
   Drawing a family tree and marking which relatives have had bleeding problems helps doctors suspect an inherited, autosomal recessive condition. The pattern of affected and unaffected family members is often typical in congenital afibrinogenemia.

7. Whole blood clotting observation (bedside clotting time)
   In some settings, a simple bedside test is performed by placing blood in a glass tube and observing how long it takes to clot. In afibrinogenemia, a firm clot may never form. While this test is crude and not specific, it can quickly show that clotting is severely impaired.

Laboratory and pathological tests

8. Plasma fibrinogen activity (Clauss method)
   This is the key test. The Clauss assay measures how long it takes to form a clot after adding high levels of thrombin to diluted plasma. In congenital afibrinogenemia, the activity level is extremely low or undetectable, confirming severe fibrinogen deficiency.

9. Fibrinogen antigen level (immunoassay)
   Immunologic tests measure the amount of fibrinogen protein (antigen), not just its function. In true afibrinogenemia, antigen levels are also extremely low or absent, matching the activity result and showing that the protein is missing rather than just abnormal.

10. Prothrombin time (PT)
    PT measures how long it takes plasma to clot through the “extrinsic” pathway. In afibrinogenemia, PT is greatly prolonged or may not clot at all, because fibrinogen is required for the final clot. This result, together with other prolonged tests, signals a severe fibrin problem.

11. Activated partial thromboplastin time (aPTT)
    aPTT measures clotting through the “intrinsic” pathway. Like PT, aPTT is very prolonged in afibrinogenemia, again because the final step of fibrin formation cannot occur. The combination of long PT and aPTT suggests a common pathway problem like fibrinogen deficiency.

12. Thrombin time (TT)
    Thrombin time measures how quickly a clot forms when thrombin is added directly to plasma. In afibrinogenemia, TT is “infinite,” meaning no clot forms, because there is no fibrinogen to be converted to fibrin. This is very helpful in spotting fibrinogen disorders.

13. Reptilase time
    Reptilase time is similar to TT but uses a snake venom enzyme instead of thrombin. It is also extremely prolonged in afibrinogenemia. Using both TT and reptilase time helps confirm that the issue is with fibrinogen rather than other parts of the clotting system.

14. Global coagulation assays (e.g., thromboelastography or ROTEM)
    Whole-blood viscoelastic tests show how a clot forms, strengthens, and breaks down over time. In afibrinogenemia, these tests often show very poor clot firmness and weak clot formation, and they are useful to follow response to fibrinogen replacement therapy.

15. Complete blood count and iron studies
    A full blood count checks hemoglobin, red cells, white cells, and platelets. In afibrinogenemia, hemoglobin may be low because of chronic or acute bleeding, while platelet counts are usually normal. Iron studies can show iron-deficiency anemia from long-term blood loss. These tests help assess the impact of bleeding.

16. Genetic testing for FGA, FGB, and FGG genes
    Molecular tests can read the DNA code of the three fibrinogen genes to find the exact mutation. Identifying the mutation confirms the diagnosis, allows carrier testing in relatives, and helps with genetic counseling and family planning.

Electrodiagnostic tests

There is no special electrodiagnostic test that directly diagnoses congenital afibrinogenemia. However, electrodiagnostic tools are sometimes used to detect or monitor complications, especially when there is bleeding in the brain or severe anemia affecting heart function.

17. Electroencephalogram (EEG)
    If intracranial bleeding causes seizures or altered consciousness, doctors may order an EEG. This test records the electrical activity of the brain through small electrodes placed on the scalp. It does not show fibrinogen levels but helps understand how the brain is functioning after a hemorrhage.

18. Electrocardiogram (ECG)
    Severe blood loss and anemia can stress the heart. An ECG records the electrical activity of the heart and can show fast heart rate, strain, or rhythm problems. Again, this does not diagnose afibrinogenemia directly but is important in managing very sick patients with major bleeding.

Imaging tests

19. Ultrasound of abdomen and pelvis
    Ultrasound uses sound waves to look inside the body. In afibrinogenemia, it helps detect internal bleeding around organs such as the liver, spleen, or uterus. It is painless, has no radiation, and is useful in children and pregnant women.

20. CT or MRI scan of the brain
    When there are symptoms like severe headache, vomiting, weakness, or seizures, brain imaging is crucial. CT scans are quick and good at showing fresh bleeding. MRI scans give more detailed pictures and can show older or smaller bleeds. These tests guide urgent treatment and can be life-saving.

21. X-ray, CT, or MRI of joints and muscles
    Imaging of joints and muscles helps detect bleeding inside these areas when a patient has pain, swelling, or limited movement. X-rays can show long-term joint damage, while MRI is best for seeing fresh blood and soft tissue involvement. This information supports the diagnosis and helps plan therapy and rehabilitation.

Non-pharmacological treatments

Below are non-drug treatments that doctors and families often use together with medicines. Each one supports safer, more stable life with congenital afibrinogenemia.

1. Bleeding-risk education and safety planning
The first “treatment” is simple knowledge. The patient and family learn which activities are risky (for example, boxing, football, high-impact sports) and how to avoid injuries at home and school. They are taught to report any new bleeding quickly, and to keep a written bleeding plan, emergency phone numbers, and hospital contacts. This education lowers the chance of serious bleeding and helps people act fast when bleeding starts. [4]

2. Medical alert card or bracelet
Doctors often advise wearing a medical ID card or bracelet that clearly says “congenital afibrinogenemia – needs fibrinogen concentrate for bleeding.” In emergencies, this tells paramedics and surgeons exactly what is wrong, so they do not give normal blood-thinning drugs and instead quickly start the right replacement therapy. This simple tool can save time and prevent wrong or delayed treatment. [5]

3. Gentle pressure, elevation, and ice for minor bleeding
For mild nosebleeds, gum bleeding, or small cuts, simple physical steps are used first. The patient or caregiver applies firm pressure with clean gauze, raises the bleeding part above heart level, and sometimes uses an ice pack through cloth. These steps slow blood flow and help the small amount of fibrin (if any) form a stable plug, while the team decides if fibrinogen replacement is needed. [6]

4. Careful dental hygiene and regular dentist visits
People with this condition often have gum bleeding. Good daily oral care (soft toothbrush, gentle floss, fluoride toothpaste) and regular dental visits reduce gum disease and infection, which can trigger bleeding. Before any dental work, the hematologist and dentist plan together; sometimes fibrinogen concentrate or local measures (like tranexamic acid mouthwash) are used around the procedure. [7]

5. Safe pregnancy and delivery planning
Women with congenital afibrinogenemia need high-risk pregnancy care. The obstetrician and hematologist plan the timing of fibrinogen infusions before labour, during delivery, and after birth to prevent severe bleeding. Delivery is usually in a hospital that has blood bank support. Sometimes a C-section is planned if it is safer. Careful planning reduces the risk to both mother and baby. [8]

6. Menstrual management without drugs (heat pads, rest, tracking)
For heavy periods, non-drug methods can help alongside medical care. Keeping a period diary, using warm pads for cramps, resting more on heavy days, and having quick access to pads or menstrual cups helps with comfort and early detection of abnormal bleeding. This record also helps doctors judge if extra treatment (like antifibrinolytic drugs or fibrinogen concentrate) is needed. [9]

7. Physiotherapy and joint protection
If someone has joint bleeding, physiotherapy is used to restore movement and strength after the acute phase. Therapists teach safe exercises, proper shoe wear, and the use of braces or supports if needed. The goal is to protect joints from repeated bleeds and long-term damage. Treatment is always coordinated with the hematologist so exercises start only when bleeding is controlled. [10]

8. Compression bandages and splints for limb bleeds
When bleeding occurs in a muscle or limb, doctors may use compression bandages or splints. These limit movement and swelling, so blood does not spread inside tissues. This is always combined with fibrinogen replacement for moderate or severe bleeds. Proper use of bandages lowers pain and reduces the risk of nerve damage from swelling. [11]

9. Avoiding intramuscular injections and risky procedures
Non-urgent intramuscular shots (for example, some vaccines, deep injections) can cause deep muscle bleeding. Doctors try to use subcutaneous or oral routes when possible. For necessary vaccinations, they may give fibrinogen first and use a very small needle with firm pressure afterward. Avoiding unnecessary invasive procedures lowers bleeding events. [12]

10. Infection prevention and routine vaccinations
Serious infections can raise bleeding risk and complicate hospital care. Patients are encouraged to have routine vaccines, hand-washing habits, and prompt treatment of infections like chest or urinary infections. If blood products are needed, doctors follow strict safety rules to minimize infection risk from transfusion. [13]

11. Pre-surgical planning meetings
Before any planned surgery, the surgeon, anesthetist, and hematologist meet to plan how much fibrinogen will be given before, during, and after surgery, and how often blood tests (fibrinogen level, clot tests) will be done. They also plan backup options like cryoprecipitate if concentrate is not available. This reduces both bleeding and clotting complications. [14]

12. Psychosocial support and school counselling
Living with a rare bleeding disorder can cause anxiety, low mood, or feeling “different” at school. Psychologists, social workers, or school counsellors can help the child and family cope, explain the condition to teachers, and plan safe participation in sports and trips. Good mental health support improves treatment adherence and quality of life. [15]

13. Genetic counselling for family planning
Because the disease is inherited, parents and adult patients may meet a genetic counsellor. They explain how the gene is passed on, options for future pregnancies, testing of family members, and prenatal or pre-implantation genetic diagnosis where available. This helps families make informed decisions and prepare early for a baby who may need special care. [16]

14. Home-treatment training (where approved)
In some countries, selected patients and families are trained to store and infuse fibrinogen concentrate at home for early treatment of bleeds, similar to home therapy in hemophilia. They learn sterile technique, dose calculation, and when to call the hospital. This can shorten time to treatment and prevent complications, but is done only under strict programs. [17]

15. Regular follow-up in a hemophilia / bleeding-disorder center
Most experts recommend care in a specialty center that sees many patients with rare bleeding disorders. The team monitors fibrinogen levels, checks for liver disease, screens for thrombosis, and adjusts prophylaxis schedules. Regular visits also allow vaccination review, dental checks, and mental health support in one place. [18]

---

Drug treatments

Again, doses below are general ranges from labels and studies and are not personal medical advice. Doctors adjust doses by weight, age, bleeding site, and lab tests.

1. Human fibrinogen concentrate – RiaSTAP
RiaSTAP is a plasma-derived fibrinogen concentrate given by vein. It is FDA-approved for treatment of acute bleeding episodes in children and adults with congenital fibrinogen deficiency, including afibrinogenemia and hypofibrinogenemia. [1] Typical dosing is calculated from body weight and desired fibrinogen level, often aiming for at least 100 mg/dL during active bleeding. Side effects include allergic reactions and an increased risk of blood clots, so monitoring is essential. [19]

2. Human fibrinogen concentrate – Fibryga
Fibryga is another human fibrinogen concentrate for intravenous use. It is FDA-approved for treatment of acute bleeding episodes in adults and adolescents with congenital fibrinogen deficiency, including afibrinogenemia. Dose is based on weight and target fibrinogen level, similar to RiaSTAP. Common side effects reported in studies include nausea, vomiting, fever, and high platelet count. Like other concentrates, it carries a risk of thrombosis, so careful lab monitoring and dose adjustment are important. [2]

3. Cryoprecipitate
Cryoprecipitate is a plasma product rich in fibrinogen and some other clotting factors. It is used when fibrinogen concentrates are unavailable. Several units are given by vein, and each unit raises fibrinogen by a small amount; repeated dosing may be needed. Infection risk is higher than with purified concentrates, and the exact fibrinogen content per unit can vary, so lab monitoring is important. Because of these limits, guidelines favor fibrinogen concentrate when possible. [3]

4. Fresh frozen plasma (FFP)
FFP is another blood product containing all clotting factors, including fibrinogen. It can be used for bleeding if no specific fibrinogen product is available. However, large volumes are needed to reach safe fibrinogen levels, so there is a higher risk of fluid overload and reactions like lung injury. For this reason, FFP is usually a backup choice, not first-line therapy, in congenital afibrinogenemia. [4]

5. Tranexamic acid (oral tablets – Lysteda and generics)
Tranexamic acid is an antifibrinolytic drug. It helps clots last longer by blocking the breakdown of fibrin. It is FDA-approved for cyclic heavy menstrual bleeding (Lysteda tablets) and used off-label to help control mucosal bleeds (nose, mouth) in bleeding disorders. Typical adult oral dosing for heavy periods is 1300 mg three times a day for up to 5 days per cycle, according to the label. Side effects can include nausea and a higher risk of blood clots, especially if used with hormonal contraceptives. [5]

6. Tranexamic acid (intravenous)
IV tranexamic acid is used in hospitals for more serious bleeds or around surgery. It is given slowly through a vein, with dose based on weight and kidney function. It must be avoided in people with active clots or certain brain bleeds. Side effects can include seizures at high doses, allergic reactions, and thrombosis, so doctors use it carefully and often for short periods only. [6]

7. Aminocaproic acid (Amicar and generics)
Aminocaproic acid is another antifibrinolytic drug that works in a similar way to tranexamic acid by blocking fibrin breakdown. It is approved by the FDA for treating bleeding due to high fibrinolysis and is sometimes used in inherited bleeding disorders for oral or nasal bleeds, dental work, or surgery. Typical adult doses for acute bleeding syndromes can be several grams per day, as per label, but must be tailored by the doctor. Side effects include muscle damage, low blood pressure, and risk of thrombosis, especially with other clotting-boosting drugs. [7]

8. Hormonal contraceptive pills for heavy periods
Combined estrogen-progestin pills can reduce menstrual blood loss by making the uterine lining thinner and regulating cycles. They are commonly used in women with bleeding disorders who have heavy periods. In afibrinogenemia, they may be combined with tranexamic acid or fibrinogen replacement when needed. However, they increase the risk of blood clots, which is important because fibrinogen concentrates already carry some thrombotic risk. Doctors balance these risks carefully. [8]

9. Progestin-only therapies and IUDs
Progestin-only pills, injections, or levonorgestrel-releasing IUDs can also reduce menstrual bleeding. They are useful when estrogen is not suitable (for example, higher clot risk). In some women with congenital afibrinogenemia, these options are used long-term to control heavy periods and prevent anemia. Side effects may include irregular spotting, weight gain, and mood changes, so ongoing follow-up is needed. [9]

10. Iron supplements and anemia medicines
Chronic bleeding may cause iron deficiency anemia. Oral iron tablets or, if needed, intravenous iron help rebuild red blood cell stores. In some cases, doctors also use erythropoiesis-stimulating agents to boost red cell production. These drugs do not fix clotting, but they improve energy, breathing, and heart function by treating anemia, which is an important part of overall care. [10]

(Many more supportive drugs may be used – for pain, infection, or surgery – but the core specific products for this disease are the fibrinogen concentrates and antifibrinolytic agents listed above.)

---

Dietary molecular supplements

Always discuss supplements with your doctor or hematology team. Some “natural” products can increase bleeding or increase clotting.

1. Oral iron (ferrous salts)
Iron tablets are a key “molecular supplement” when there is chronic blood loss. They help the bone marrow make new red cells by providing the iron needed for hemoglobin. Usual doses are divided through the day, often taken with vitamin C to improve absorption. Side effects can include stomach upset and constipation. Correcting iron deficiency reduces fatigue and dizziness from anemia. [1]

2. Folic acid
Folate is a B-vitamin needed for DNA synthesis in red blood cell production. Extra folic acid is sometimes given when there is ongoing bleeding or pregnancy, to help the bone marrow keep up with demand. Typical small daily doses are used, as advised by the doctor. It does not change clotting directly but supports healthy blood formation. [2]

3. Vitamin B12
Vitamin B12 deficiency can worsen anemia and fatigue. In people with poor diet or absorption problems, B12 injections or tablets may be prescribed. Adequate B12 allows normal red blood cell maturation and helps nerve function. It is not specific for afibrinogenemia but is part of general hematologic health. [3]

4. Vitamin C
Vitamin C helps the body absorb iron from the gut and supports collagen in blood vessel walls, which may reduce easy bruising. Small daily doses (from food or supplements) are often enough. Very high doses are usually avoided because they may cause stomach upset or kidney stones. [4]

5. Vitamin D and calcium
People who avoid sports or sunlight because of bleeding risk can develop weak bones. Vitamin D and calcium supplements help maintain bone strength and reduce fracture risk. Doctors may check vitamin D levels and adjust dose. Strong bones are important because fractures and falls can cause serious bleeding in this condition. [5]

6. Omega-3 fatty acids (with caution)
Omega-3 fatty acids from fish oil or flaxseed are sometimes used for heart health. However, high doses may slightly increase bleeding time, so doctors often avoid large omega-3 supplements in people with severe bleeding disorders. If used at low doses for general health, it should be under hematologist advice. [6]

7. Protein-rich diet
Although not a pill, a diet with enough high-quality protein (beans, lentils, eggs, dairy, fish, lean meat) gives the liver the building blocks to make proteins, including clotting factors in people who can produce them. In afibrinogenemia, fibrinogen production is genetically absent, but good protein intake still supports overall health, wound healing, and immune function. [7]

8. Multivitamin without high-dose vitamin E
A simple multivitamin can be useful when diet is poor. However, high doses of vitamin E can increase bleeding tendency, so formulations with normal or low vitamin E are preferred. Patients should show any supplement label to their hematologist before starting it. [8]

9. Probiotics (for gut health during iron or drug therapy)
Iron tablets and some drugs may disturb the gut and cause constipation or diarrhea. Probiotic foods (yogurt with live cultures) or supplements may help keep the gut flora balanced. A healthy gut also improves nutrient absorption, which is important in people with chronic illness. [9]

10. Hydration and electrolyte balance
Again, not a pill, but good hydration supports circulation and kidney function, especially when receiving IV products or antifibrinolytics. Oral rehydration solutions may be used after heavy bleeding or diarrhea. Balanced fluids help the body cope with stress and drug clearance. [10]

---

Immunity-booster, regenerative and stem-cell–related drugs

For congenital afibrinogenemia, true “stem cell” cures are not standard. The main therapy is lifelong replacement. A few advanced or supportive options are discussed in rare or research settings.

1. Vaccines (as immune boosters in general)
Routine vaccines (influenza, pneumococcal, COVID-19, etc.) are key “immune boosters.” They teach the immune system to fight infections, which otherwise can lead to hospitalisation, surgery, or blood product use, all of which increase bleeding risk. Vaccines are scheduled carefully with attention to injection sites and pressure afterward. [1]

2. Immunoglobulin therapy (only for specific indications)
If a patient also has immune deficiency or immune-related complications, IV immunoglobulin (IVIG) may be used. It provides pooled antibodies from donors to help fight infections or modulate the immune system. It does not replace fibrinogen but can indirectly reduce infection-triggered bleeding episodes. [2]

3. Hematopoietic stem cell transplantation (HSCT – experimental for this disorder)
In theory, a bone marrow or stem cell transplant could replace the defective liver-derived fibrinogen-producing cells. In practice, HSCT is very high risk and is not routine therapy for congenital afibrinogenemia. It may be considered only in very rare cases with severe combined problems and available matched donor, usually as part of research. Risks include infection, graft-versus-host disease, infertility, and death, so benefits must clearly outweigh these dangers. [3]

4. Future gene therapy (research stage)
Scientists are exploring gene therapy, where a working copy of the fibrinogen gene is delivered to liver cells using viral vectors. This could, in the future, allow the body to make its own fibrinogen. At present, this is experimental and not approved treatment, but it is an area of active research in many inherited bleeding disorders. [4]

5. Hepatocyte-targeted therapies
Some research looks at delivering corrected genes or cells specifically to the liver, which makes fibrinogen. Any such therapy would try to restore more normal fibrinogen production and reduce the need for infusions. Right now, these ideas are still in pre-clinical or early clinical study stages and not part of routine care. [5]

6. Supportive drugs that protect organs (for example, ACE inhibitors, statins – when indicated)
In adults with long-term disease and multiple transfusions or risk factors, doctors sometimes use drugs that protect the heart, kidneys, or liver (such as ACE inhibitors or statins) when otherwise indicated. These drugs do not change fibrinogen but can reduce organ damage and improve long-term health, which indirectly improves recovery from bleeds and surgeries. [6]

---

Surgeries (Procedures and why they are done)

1. Emergency surgery for life-threatening internal bleeding
If bleeding occurs in the brain, abdomen, or another vital area, emergency surgery may be needed to remove clots, repair torn vessels, or relieve pressure. Before and during surgery, high doses of fibrinogen concentrate are given to reach safe levels, and antifibrinolytics may be added. The goal is to save life and prevent permanent damage. [1]

2. Orthopedic surgery for damaged joints
Repeated joint bleeds can cause chronic pain and deformity. When joints are badly damaged, orthopedic surgery (such as synovectomy or joint replacement) may be performed. Fibrinogen levels are closely controlled before, during, and after surgery to prevent bleeding and clots. The purpose is to improve mobility, reduce pain, and allow safer activity. [2]

3. Obstetric procedures (C-section, repair of tears)
During childbirth, women with afibrinogenemia may need a planned C-section or surgical repair of tears after vaginal delivery. The team raises fibrinogen to safe levels before the procedure and maintains it in the postpartum period. The aim is to prevent life-threatening postpartum hemorrhage while giving the safest delivery for mother and baby. [3]

4. Dental and oral surgery
Tooth extractions, gum surgeries, or jaw operations in these patients are managed like “mini-surgeries.” Fibrinogen replacement, local antifibrinolytic rinses, and suturing techniques are used to control bleeding. The goal is to treat dental disease while avoiding excessive blood loss and the need for hospital admission. [4]

5. Placement of central venous access devices
Some patients who need frequent infusions receive a central venous catheter or port. This is placed surgically under controlled conditions with fibrinogen at safe levels. It allows easier, less painful access for future fibrinogen infusions, especially in children or people with poor veins. The benefit is quicker treatment and better quality of life. [5]

---

Prevention

1. Avoid high-impact and contact sports (boxing, rugby, martial arts). Choose safer activities like walking, swimming, or cycling with a helmet. [1]

2. Use protective gear (helmets, knee pads, elbow pads) when doing any activity with fall risk.

3. Keep a bleeding action plan at home and school, including emergency contacts and hospital instructions.

4. Maintain good dental care to prevent gum disease and dental procedures that can cause bleeding.

5. Plan pregnancies and surgeries early with a hematologist and specialist team.

6. Avoid unnecessary injections and piercing/tattoos, which may cause deep tissue bleeding.

7. Check all medicines and supplements with the hematology team, especially anything that affects clotting (aspirin, NSAIDs, high-dose vitamin E, fish oil).

8. Keep vaccinations up to date to reduce serious infections that could trigger complicated care.

9. Attend all follow-up appointments at the bleeding-disorder center for monitoring and education.

10. Wear a medical alert bracelet or card so emergency teams know the diagnosis immediately. [2]

---

What to eat and what to avoid

1. Eat iron-rich foods like red meat (if allowed), liver, beans, lentils, spinach, and fortified cereals to help prevent anemia. [1]

2. Include vitamin-C-rich fruits (oranges, guava, lemons) to improve iron absorption.

3. Choose enough protein from eggs, dairy, fish, poultry, tofu, and legumes to support healing and general health.

4. Maintain a healthy weight; obesity raises surgical risk and may increase clot risk when on concentrates and hormonal therapy.

5. Limit alcohol, which can damage the liver and worsen clotting problems.

6. Avoid fad diets that severely cut calories or major food groups, as these can cause nutrient deficiencies.

7. Use caution with herbal remedies like ginkgo, garlic pills, and high-dose ginger, which may increase bleeding.

8. Avoid very high-dose vitamin E and large omega-3 supplements unless a hematologist approves them.

9. Drink enough water to support kidney function and drug clearance.

10. Ask your doctor before starting any “immune booster” supplement, because some products are poorly studied and may interact with your medicines. [2]

---

When to see a doctor

You should contact your doctor or go to the emergency room immediately if:

• You have sudden, severe headache, confusion, or weakness, which could mean bleeding in the brain.

• You notice vomit or stool that is bright red or black, which may mean stomach or bowel bleeding.

• Bleeding from a cut or nose does not stop after 20 minutes of firm pressure.

• A joint or muscle becomes very painful, swollen, or hard, especially after a minor bump.

• A woman has very heavy periods (changing pads every hour, passing large clots, or feeling dizzy).

• You feel short of breath, chest pain, or leg swelling, which may be signs of a blood clot (thrombosis).

You should also see your hematologist regularly for check-ups, even when you feel well, to review your treatment plan, update vaccinations, and discuss school, work, or pregnancy plans. [1]

---

Frequently asked questions (FAQs)

1. Is congenital afibrinogenemia curable?
Right now, there is no simple cure. The main treatment is lifelong fibrinogen replacement with concentrates like RiaSTAP or Fibryga and careful bleeding prevention. Research into gene therapy and stem-cell approaches is ongoing but still experimental. [1]

2. Can a child with afibrinogenemia live a normal life?
With modern fibrinogen concentrates, good education, and care in a bleeding-disorder center, many children can attend school, play safe sports, and grow into adults with good quality of life. Some activities must be adapted, but many everyday goals are still possible. [2]

3. How often are fibrinogen infusions needed?
Infusions are given when there is bleeding or before surgery or dental work. Some patients with very severe disease or past life-threatening bleeds may receive regular prophylactic infusions, for example once a week, but schedules are personalized. [3]

4. Are fibrinogen concentrates safe?
Modern concentrates are made from screened donor plasma and include virus-removal steps. They greatly reduce infection risk compared with older products. However, they can still cause allergic reactions and increase the risk of blood clots, so doctors watch closely and use the lowest effective dose. [4]

5. Why are cryoprecipitate and FFP still used sometimes?
In some countries, fibrinogen concentrate may not be available or may be too expensive. In these settings, cryoprecipitate or FFP are used as alternatives, even though they have higher infection and volume risks. When possible, guidelines prefer concentrate because it is more precise and safer. [5]

6. Can I take painkillers like ibuprofen or aspirin?
Usually no. Aspirin and many NSAIDs like ibuprofen can increase bleeding by affecting platelets. Most hematologists recommend paracetamol (acetaminophen) for pain, but you should always check with your doctor before taking any new medicine. [6]

7. Is pregnancy possible with congenital afibrinogenemia?
Yes, many women with this condition have successful pregnancies, but they are considered high risk. Close monitoring, planned fibrinogen infusions, and delivery in a specialist center are essential to manage bleeding risk during pregnancy, delivery, and after birth. [7]

8. Can afibrinogenemia cause blood clots as well as bleeding?
Surprisingly, yes. Even though fibrinogen is low, some patients develop thrombosis, especially when receiving high doses of fibrinogen concentrate or other pro-thrombotic drugs like hormonal contraceptives. This is why doctors monitor for both bleeding and clots. [8]

9. Should brothers and sisters be tested?
Because the disease is inherited, it is often helpful to test siblings, especially before surgery, dental work, or sports that carry higher risk. Genetic counselling can explain pros and cons of testing and what results mean for the family. [9]

10. Can I travel if I have congenital afibrinogenemia?
Yes, but travel needs extra planning. You may need to carry letters from your hematologist, a supply of medicine if allowed, medical ID, and a list of hospitals with hematology services at your destination. Long plane flights may increase clot risk, so your doctor may give special advice. [10]

11. Can diet alone control this condition?
No. Diet can support general health and treat anemia, but it cannot replace missing fibrinogen. Only fibrinogen concentrates or plasma products can correct the clotting defect during bleeding. Healthy eating is still important but is not enough by itself. [11]

12. Is home infusion safe?
In experienced centers, selected patients and families can safely do home infusions after training. They learn about dosing, sterile technique, and when to call for help. Home therapy can shorten time to treatment and reduce hospital visits, but it is not right for everyone and must follow strict protocols. [12]

13. What tests are used to monitor treatment?
Doctors use plasma fibrinogen levels, global clotting tests (like PT, aPTT), and sometimes viscoelastic tests (such as ROTEM or TEG) to see whether fibrinogen replacement is working. They may also monitor for signs of thrombosis with imaging if symptoms appear. [13]

14. What happens if treatment is delayed during a bleed?
Delayed treatment can allow bleeding to spread, causing nerve damage, joint destruction, or life-threatening complications like brain hemorrhage. This is why early recognition, quick pressure or immobilization, and fast hospital contact are vital for every patient and family. [14]

15. Who should coordinate my care?
Ideally, a hematologist with experience in rare bleeding disorders leads the team, working with pediatricians, obstetricians, surgeons, dentists, physiotherapists, and mental-health staff. This team care model has been shown to improve outcomes and quality of life in people with rare bleeding conditions. [15]

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: March 05, 2025.